BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced its strategic plan to transition from a prescription to a non-prescription business model. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback